OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
Part of paid clinical trials in Morgantown, West Virginia.
- Sponsor
- West Virginia University
- Study ID
- NCT01052363
- Phase
- PHASE1
- Status
- Withdrawn
Conditions
- Central Nervous System Tumors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab, CA4P — DRUG
Study Details
Pilot Trial of CA4P with Avastin in Recurrent Gliomas
Key Dates
- First listed
- Jan 20, 2010
- Start date
- Jan 31, 2010
- Status verified
- Feb 2017
Study Design
- Enrollment
- 0 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CA4P + Avastin
- Experimental: Avastin + CA4P
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MBRCC, West Virginia University | Morgantown | West Virginia | 26506 | - |
Find similar trials in Morgantown, WV
By research site
Related Studies
- A Study of Mirdametinib in People With Central Nervous System TumorsPHASE1/PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey